Standard Life Aberdeen »

Structure Therapeutics shares owned by Standard Life Aberdeen

Quarter-by-quarter ownership of Structure Therapeutics (GPCR) shares owned by Standard Life Aberdeen from 13F filings

Historical chart of Standard Life Aberdeen investment in Structure Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Structure Therapeutics held by Standard Life Aberdeen consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Structure Therapeutics by Standard Life Aberdeen

Quarter filed Position value Share count Share price at filing
2024-09-30 $9.5M 217k 43.89
2024-06-30 $3.7M 93k 39.27

More positions owned by Standard Life Aberdeen

Apple (AAPL)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Alphabet Cap Stk Cl C (GOOG)
Eli Lilly & Co. (LLY)
Meta Platforms Cl A (META)
Tesla Motors (TSLA)
UnitedHealth (UNH)
Broadcom (AVGO)
Mastercard Incorporated Cl A (MA)
Merck & Co (MRK)
Coca-Cola Company (KO)
Procter & Gamble Company (PG)

View all positions for Standard Life Aberdeen

Top funds holding Structure Therapeutics

Capital Research Global Investors
Henderson Group
Driehaus Capital Management
Federated Investors
BVF
T. Rowe Price Associates
RA Capital Management
Citadel Advisors
Logos Global Management
Capital Research and Management Company - Division 3
Point72 Asset Management
Octagon Capital Advisors
Vestal Point Capital
Rock Springs Capital Management
Deep Track Capital

View all funds holding Structure Therapeutics